Eosinophilic esophagitis (EoE) is diagnosed through an upper endoscopy with tissue biopsies, looking for a specific type of white blood cell called an eosinophil in the lining of the esophagus. A count of 15 or more eosinophils per high-power field on microscopy is the threshold that confirms the diagnosis. There is no blood test, imaging scan, or allergy panel that can diagnose EoE on its own.
What Happens During the Endoscopy
The central diagnostic procedure is an upper endoscopy, where a thin, flexible tube with a camera is passed through the mouth and into the esophagus while you’re sedated. The gastroenterologist visually inspects the esophagus for signs of the disease and takes small tissue samples (biopsies) for analysis under a microscope.
During the visual exam, the doctor scores five specific features using what’s known as the EREFS system: edema (swelling of the tissue), rings (circular ridges that give the esophagus a corrugated appearance), exudates (white spots or plaques on the surface), furrows (vertical lines running along the esophageal wall), and strictures (narrowing). Each feature is rated on a severity scale, and together they give a picture of how active and advanced the disease is. Some people with EoE have dramatic visual findings, while others have an esophagus that looks relatively normal, which is why biopsies are essential regardless of appearance.
How Biopsies Are Taken and Analyzed
Current guidelines recommend at least two to four biopsies from the upper esophagus and two to four from the lower esophagus, for a minimum of four to eight samples total. Eosinophils in EoE tend to cluster in patches rather than spreading evenly, so sampling from multiple locations reduces the chance of missing an affected area. Studies in both adults and children show that sensitivity is maximized when at least five biopsies are obtained.
A pathologist examines these tissue samples under a microscope. The defining finding is 15 or more eosinophils in a single high-power field. But pathologists also look for secondary features that round out the picture. Basal cell hyperplasia, where the deepest layer of esophageal cells expands and takes up more of the tissue thickness than it should, is one common finding. Spongiosis, a widening of the spaces between cells that makes the tissue look sponge-like, is another. Research has found that basal cell hyperplasia in particular correlates with ongoing symptoms and visible endoscopic changes, even in patients whose eosinophil counts have dropped below the diagnostic threshold after treatment.
A PPI Trial Is No Longer Required
For years, doctors were required to put patients on a course of acid-reducing medication (a proton pump inhibitor, or PPI) before they could formally diagnose EoE. The reasoning was that acid reflux (GERD) can also cause eosinophils to accumulate in the esophagus, and a PPI trial was supposed to separate the two conditions. If eosinophils went away with a PPI, the diagnosis was GERD. If they persisted, the diagnosis was EoE.
That requirement has been removed. An international consensus conference voted unanimously to drop the PPI trial from the diagnostic criteria after evidence showed that PPIs can treat EoE directly, not just GERD. The current understanding is that PPIs are a treatment option for EoE itself, not a diagnostic tool for ruling it out. This means your doctor can diagnose EoE based on your symptoms, endoscopic findings, and biopsy results without waiting weeks for a PPI trial first.
Why Blood Tests and Allergy Panels Fall Short
EoE is an immune-driven condition often linked to food allergies, so it might seem logical that a blood test or skin prick test could point to the diagnosis. In practice, no blood-based biomarker is reliable enough for routine use. Total IgE levels in the blood do not correlate with EoE disease activity, and food-specific IgE tests and skin prick testing do not reliably identify which foods are triggering the condition. This is because EoE involves a different arm of the immune system than classic food allergies like anaphylaxis. Almost all standard allergy testing is designed to detect IgE-mediated reactions, which have only minimal value in identifying the foods driving EoE.
This is a source of real frustration for patients and families who would prefer a simple blood draw over repeated endoscopies. For now, biopsy remains the only validated way to diagnose and monitor the disease.
Symptoms That Lead to Testing
The symptoms that prompt an EoE workup differ significantly by age. Adults typically present with difficulty swallowing solid foods and episodes of food getting stuck in the esophagus (food impaction). These are often the result of years of chronic inflammation that has led to scarring and narrowing of the esophagus.
Children, especially younger ones, may not be able to describe swallowing difficulty. Instead, they present with feeding difficulties, food refusal, vomiting, abdominal pain, or poor growth. The same diagnostic criteria apply to both children and adults: 15 or more eosinophils per high-power field on biopsy. The differences are largely in how the disease manifests, because the fibrous remodeling that causes strictures and narrowing tends to develop over time. This is one reason early diagnosis matters, since catching and treating the inflammation before significant scarring occurs can change the long-term course of the disease.
Preparing for the Procedure
An upper endoscopy is typically an outpatient procedure that takes 15 to 30 minutes. You’ll need to stop eating solid food for eight hours and stop drinking liquids for four hours beforehand. If you take blood thinners, your doctor will give you specific instructions about when to pause them, since biopsies carry a small bleeding risk. Make sure to share a full list of your medications and supplements before the procedure. You’ll be sedated, so you’ll need someone to drive you home, and most people can resume normal eating later that day.
Less Invasive Alternatives Under Development
Because EoE requires repeat endoscopies to check whether treatment is working, there’s strong interest in less invasive monitoring tools. The most studied is the Cytosponge: a small gelatin capsule on a string that you swallow. Once the capsule dissolves in the stomach, a mesh sponge expands and is pulled back up through the esophagus by the string, collecting tissue along the way. In studies, the Cytosponge detected active EoE (15 or more eosinophils per high-power field) with 75% sensitivity and 86% specificity, and patients rated it significantly more acceptable than standard endoscopy. About 7% of participants couldn’t swallow the capsule, and some reported a transient sore throat, but there were no serious side effects.
The esophageal string test is another option being explored. It involves swallowing a string that sits in the esophagus for an extended period and absorbs proteins associated with inflammation. It doesn’t carry a risk of esophageal abrasion but requires a long dwell time and doesn’t produce a tissue sample that can be examined under a microscope. Transnasal endoscopy, a thinner scope passed through the nose that may not require sedation, has also shown promise in small studies. None of these tools have replaced standard endoscopy with biopsy in routine practice, but they may eventually reduce the number of full sedated procedures patients need over a lifetime of managing EoE.